Trying to confirm research findings by repeating experiments in mice may be as ineffective as a coin toss, say scientists who claim to have exposed a problem which potentially affects many studies in experimental biomedicine.
Scientists at Berlin Institute of Health (BIH) and Charite -Universitatsmedizin Berlin in Germany conducted a provocative and seemingly absurd experiment.
Instead of repeating an experiment in a mouse model of disease in their laboratory, researchers used a coin toss to confirm whether a drug protects the brain against a stroke, for a study published in the journal PLOS Biology.
The researchers said that small sample sizes, often below 10, and almost universally loose thresholds for accepting statistical significance (5 per cent) lead to a high rate of false positive results and an overestimation of true effects.
Their study alerts researchers that, contrary to common expectation, replication of a study -- in settings which are common in many laboratories worldwide -- may not add more evidence to what could be gained from tossing a coin.
Many research fields are struggling with what has been termed "the replication crisis." Quite often results from one laboratory cannot be replicated by researchers in another lab, with successful replication rates often falling below 50 per cent.
This has shaken confidence in the robustness of the scientific enterprise in general and stimulated a search for underlying causes.
Toward this end, many researchers have started to repeat experiments within their laboratories as an integral part of robust science and good scientific practice.
In the new research paper, the team scrutinised the utility of replicating experiments within laboratories and send a surprising message of caution regarding current replication practices.
They provide detailed theoretical and practical background for how to properly conduct and report replication studies to help scientists save resources and prevent futile use of animals, while increasing the robustness and reproducibility of their results.
"Replication is fundamental to the scientific process. We can learn from successful and from failed replication -- but only if we design, perform, and report them properly," researchers said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
